The Establishment of Dendritic Cell-Tumor Fusion Vaccines for Hormone Refractory Prostate Cancer Cell

PURPOSE: Dendritic cell (DC)-based tumor vaccine is an attractive modality for the treatment of hormone-refractory prostate cancer (HRPC) because it has some efficacy and few side effects in patients with poor general conditions. The aim of this study was to establish which is the most effective DC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Tae-Beom, Park, Ho Ki, Chang, Joo Hyun, Choi, In Ho, Kim, Khae Hawn, Yoon, Sang Jin, Lee, Min Sung, Jung, Han, Kim, Choung-Soo
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Urological Association 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2855480/
https://ncbi.nlm.nih.gov/pubmed/20414428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2010.51.2.139
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados